South Carolina Cancer Specialists PC
Hilton Head Island, South Carolina, United States
Cancer treatment center in Hilton Head, South Carolina
45 Hospital Center Commons, Hilton Head Island, SC 29926
About South Carolina Cancer Specialists PC
"Board certified Medical Oncology/Hematology office"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
17
Alliance for Clinical Trials in Oncology
8
NRG Oncology
5
ECOG-ACRIN Cancer Research Group
4
SWOG Cancer Research Network
4
Helsinn Therapeutics (U.S.), Inc
3
Wake Forest University Health Sciences
3
Celgene
2
American Society of Clinical Oncology
1
CTI BioPharma
1
Hoosier Cancer Research Network
1
Clinical Trials at South Carolina Cancer Specialists PC
During the past decade, South Carolina Cancer Specialists PC conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 7 clinical trials were completed, i.e. on
average, 18.4% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 4 clinical trials were completed. i.e. 44.4%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
St. John's Wort in Relieving Hot Flashes in Postmenopausal Women With Non-Metastatic Breast Cancer
2006-03-16
2008-04-01
Terminated
9
Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia.
2005-11-01
2006-10-01
Completed
DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])
2006-01-01
2007-11-01
Terminated
1,200
Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia
2006-09-01
2007-04-01
Completed
51
Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer
2008-03-01
2009-12-01
Completed
228
A Study to Determine the Efficacy and Safety of Lenalidomide in Patients With Mantle Cell NHL Who Have Relapsed or Progressed After Treatment With Bortezomib or Are Refractory to Bortezomib. The "EMERGE" Trial
2008-12-22
2017-11-08
Completed
134
Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer
2009-07-09
2019-10-04
Completed
2,840
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
2009-10-13
2018-05-09
Completed
450
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "South Carolina Cancer Specialists PC" #1 sponsor was "National Cancer Institute (NCI)" with 17 trials, followed by "Alliance for Clinical Trials in Oncology" with 8 trials
sponsored, "NRG Oncology" with 5 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "SWOG Cancer Research Network"
with 4 trials sponsored. Other sponsors include 10 different institutions and
companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "South Carolina Cancer Specialists PC"
#1 collaborator was "National Cancer Institute (NCI)" with 24 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator and "Bayer" with 2 trials as a collaborator. Other collaborators include 11 different institutions and companies that were
collaborators in the rest 20 trials.
Clinical Trials Conditions at South Carolina Cancer Specialists PC
According to Clinical.Site data, the most researched conditions in "South Carolina Cancer Specialists PC" are
"Invasive Breast Carcinoma" (5 trials), "Anatomic Stage II Breast Cancer AJCC v8" (4 trials), "Anatomic Stage IIA Breast Cancer AJCC v8" (4 trials), "Anatomic Stage IIB Breast Cancer AJCC v8" (4 trials) and "Anatomic Stage IIIA Breast Cancer AJCC v8" (4 trials). Many other conditions were trialed in "South Carolina Cancer Specialists PC" in a lesser frequency.
Clinical Trials Intervention Types at South Carolina Cancer Specialists PC
Most popular intervention types in "South Carolina Cancer Specialists PC" are "Drug" (41 trials), "Other" (32 trials), "Biological" (15 trials), "Procedure" (15 trials) and "Radiation" (5 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (15 trials), "Questionnaire Administration" (13 trials), "Paclitaxel" (11 trials), "Biospecimen Collection" (10 trials) and "Carboplatin" (10 trials). Other intervention names were less common.
Clinical Trials Genders at South Carolina Cancer Specialists PC
The vast majority of trials in "South Carolina Cancer Specialists PC" are
41 trials for "All" genders, 9 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at South Carolina Cancer Specialists PC
Currently, there are NaN active trials in "South Carolina Cancer Specialists PC".
undefined are not yet recruiting,
22 are recruiting,
17 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in South Carolina Cancer Specialists PC,
1 suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in South Carolina Cancer Specialists PC, 2 "Phase 1"
clinical trials were conducted, 19 "Phase 2" clinical
trials and 30 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".